Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: A dose accumulation comparison

被引:64
|
作者
Vestergaard, Anne [1 ]
Muren, Ludvig Paul [1 ,2 ]
Sondergaard, Jimmi [2 ]
Elstrom, Ulrik Vindelev [1 ]
Hoyer, Morten [2 ]
Petersen, Jorgen B. [1 ]
机构
[1] Aarhus Univ Hosp, Dept Med Phys, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
关键词
Adaptive radiotheraphy; Bladder cancer; Plan-of-the-day; Re-optimisation; Dose accumulation; INTENSITY-MODULATED RADIOTHERAPY; IMAGE-GUIDED RADIOTHERAPY; RADICAL RADIOTHERAPY; MARGINS; TARGET; ORGAN; CT; PROPAGATION; STRATEGIES; VOLUMES;
D O I
10.1016/j.radonc.2013.08.045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Patients with urinary bladder cancer are obvious candidates for adaptive radiotherapy (ART) due to large inter-fractional variation in bladder volumes. In this study we have compared the normal tissue sparing potential of two ART strategies: daily plan selection (PlanSelect) and daily plan re-optimisation (ReOpt). Materials and methods: Seven patients with bladder cancer were included in the study. For the PlanSelect strategy, a patient-specific library of three plans was generated, and the most suitable plan based on the pre-treatment cone beam CT (CBCT) was selected. For the daily ReOpt strategy, plans were re-optimised based on the CBCT from each daily fraction. Bladder contours were propagated to the CBCT scan using deformable image registration (DIR). Accumulated dose distributions for the ART strategies as well as the non-adaptive RT were calculated. Results: A considerable sparing of normal tissue was achieved with both ART approaches, with ReOpt being the superior technique. Compared to non-adaptive RT, the volume receiving more than 57 Gy (corresponding to 95% of the prescribed dose) was reduced to 66% (range 48-100%) for PlanSelect and to 41% (range 33-50%) for ReOpt. Conclusion: This study demonstrated a considerable normal tissue sparing potential of ART for bladder irradiation, with clearly superior results by daily adaptive re-optimisation. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 50 条
  • [31] Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit
    R. de Jong
    K. F. Crama
    J. Visser
    N. van Wieringen
    J. Wiersma
    E. D. Geijsen
    A. Bel
    Radiation Oncology, 15
  • [32] Online adaptive radiotherapy compared to plan selection for rectal cancer: quantifying the benefit
    de Jong, R.
    Crama, F.
    Visser, J.
    van Wieringen, N.
    Wiersma, J.
    Geijsen, E. D.
    Bel, A.
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [33] Quantifying the benefit of online adaptive radiotherapy for rectal cancer compared to plan selection
    De Jong, R.
    Visser, J.
    Crama, K.
    Van Wieringen, N.
    Wiersma, J.
    Geijsen, D.
    Bel, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S242 - S242
  • [34] Dosimetric plan comparison: proton radiotherapy vs. helical intensity modulated radiotherapy with photons in patients with mediastinal lymphomas
    Koenig, L.
    Haefner, M.
    Rieber, J.
    Chaudry, N.
    Mielke, T.
    Debus, J.
    Herfarth, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 16 - 16
  • [35] Comparison of different strategies for deformable dose accumulation in prostate cancer radiotherapy
    Murr, M.
    Wegener, D.
    Nachbar, M.
    Mueller, A.
    Zips, D.
    Thorwarth, D.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1511 - S1512
  • [36] AN ANALYSIS ON DOSE COVERAGE IN BLADDER CANCER USING THE TOMOTHERAPY ADAPTIVE RADIOTHERAPY APPLICATION
    Althof, V.
    Niel, C.
    Altena, W.
    Bekhuis, E.
    Geukes, L.
    Oplaat, M.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S441 - S441
  • [37] UNRESECTABLE ESOPHAGEAL CANCER TREATED WITH RADIOTHERAPY (LOW DOSE VS. HIGH) AND CHEMOTHERAPY
    Boladeras Inglada, A. M.
    Cambray, M.
    Navarro, V.
    Macia, M.
    Agut, M.
    Modolell I Farre, I.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S296 - S296
  • [38] Dose-volume Effects of IMRT vs. non-IMRT in definitive Radiotherapy of muscle-invasive Bladder Cancer
    Fischer, Laura Anna
    Schirmer, Markus Anton
    Fischer, Jann
    Ziegler, David Alexander
    Possiel, Jacqueline
    Hille, Andrea
    Droege, Leif Hendrik
    Guhlich, Manuel
    Knaus, Olga
    Bendrich, Stephanie
    Trojan, Lutz
    Florian, Puetsch
    Strauss, Arne
    Reichert, Mathias
    Braulke, Friederike
    Rieken, Stefan
    El Shafie, Rami
    STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S152 - S152
  • [39] Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients
    Horlemann, Benedikt
    Wurnschimmel, Christoph
    Hoeh, Benedikt
    Sorce, Gabriele
    Chierigo, Francesco
    Flammia, Rocco Simone
    Tian, Zhe
    Saad, Fred
    Briganti, Alberto
    Shariat, Sharokh F.
    Galucci, Michele
    Chun, Felix K. H.
    Graefen, Markus
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2022, 20 (01) : 93 - +
  • [40] Radiotherapy vs. Cystectomy for Treatment of Muscle Invasive Bladder Cancer in Very Elderly Patients
    Frick, M. A.
    Ogunkeye, J.
    Oladipo, E. D.
    Prado, K.
    Bagshaw, H. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E383 - E384